Showing results (1-10 of 190) with videos related to

Sort By:
Pageof 19
British Journal of Pharmacology|September 8, 2011
Human obesity and endothelium-dependent responsivenessUmberto Campia, Manfredi Tesauro, Carmine Cardillo
Vascular Pharmacology|April 1, 2020
Increased fractalkine and vascular dysfunction in obesity and in type 2 diabetes. Effects of oral antidiabetic treatmentFrancesca Schinzari, Manfredi Tesauro, Umberto Campia, et al.
Life Sciences|March 11, 2014
The vascular endothelin system in obesity and type 2 diabetes: pathophysiology and therapeutic implicationsUmberto Campia, Manfredi Tesauro, Nicola Di Daniele, et al.
Vascular Medicine (London, England)|April 10, 2023
Variable dysregulation of circulating lipocalin-2 in different obese phenotypes: Association with vasodilator dysfunctionFrancesca Schinzari, Giuseppina Vizioli, Umberto Campia, et al.
Biomedicines|August 27, 2021
Variable Changes of Circulating ANGPTL3 and ANGPTL4 in Different Obese Phenotypes: Relationship with Vasodilator DysfunctionFrancesca Schinzari, Giuseppina Vizioli, Umberto Campia, et al.
Atherosclerosis|April 29, 2014
PPARγ activation does not affect endothelin activity in non-diabetic patients with hypertension or hypercholesterolemiaUmberto Campia, Linda A Matuskey, Manfredi Tesauro, et al.
Plos One|March 26, 2015
Sex-specific effects of cardiovascular risk factors on endothelium-dependent dilation and endothelin activity in middle-aged women and menVijaywant Brar, Sartaj Gill, Carmine Cardillo, et al.
American Journal of Physiology. Endocrinology and Metabolism|August 14, 2019
Calcification biomarkers and vascular dysfunction in obesity and type 2 diabetes: influence of oral hypoglycemic agentsFrancesca Schinzari, Manfredi Tesauro, Aldo Bertoli, et al.
American Journal of Physiology. Endocrinology and Metabolism|September 17, 2015
Vasodilator responses and endothelin-dependent vasoconstriction in metabolically healthy obesity and the metabolic syndromeFrancesca Schinzari, Micaela Iantorno, Umberto Campia, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 26, 2012
Rho-kinase inhibition improves vasodilator responsiveness during hyperinsulinemia in the metabolic syndromeFrancesca Schinzari, Manfredi Tesauro, Valentina Rovella, et al.
Pageof 19